Marco Londei
2018
In 2018, Marco Londei earned a total compensation of $2.5M as Chief Medical Officer at ANAPTYSBIO, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,320 |
|---|---|
| Option Awards | $1,912,856 |
| Salary | $436,000 |
| Other | $3,564 |
| Total | $2,513,740 |
Londei received $1.9M in option awards, accounting for 76% of the total pay in 2018.
Londei also received $161.3K in non-equity incentive plan, $436K in salary and $3.6K in other compensation.
Rankings
In 2018, Marco Londei's compensation ranked 4,633rd out of 14,244 executives tracked by ExecPay. In other words, Londei earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,633 out of 14,244 | 68th |
Division Manufacturing | 1,744 out of 5,765 | 70th |
Major group Chemicals And Allied Products | 630 out of 2,128 | 70th |
Industry group Drugs | 528 out of 1,817 | 71st |
Industry Pharmaceutical Preparations | 408 out of 1,391 | 71st |
Source: SEC filing on April 26, 2019.
Londei's colleagues
We found three more compensation records of executives who worked with Marco Londei at ANAPTYSBIO in 2018.